Bruton’s tyrosine kinase in chronic inflammation: from pathophysiology to therapy

Overview of attention for article published in International journal of interferon cytokine and mediator research IJIM, September 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)

Mentioned by

blogs: 1 blog

patent: 6 patents

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 13 Mendeley

Summary Blogs Patents Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Targeting Multiple End Organs in Lupus and Other Systemic Rheumatic Diseases by Inhibiting Bruton’s Tyrosine Kinase

Article in Frontiers in Immunology (July 2022)

Mechanisms of ibrutinib resistance in chronic lymphocytic leukemia and alternative treatment strategies

Article in Expert Review of Hematology (August 2020)

The development of Bruton's tyrosine kinase (BTK) inhibitors from 2012 to 2017: A mini-review

Article in European Journal of Medicinal Chemistry (March 2018)